Department of Nuclear Medicine

Organization profile

Organisation profile

Nuclear medicine is a branch of medicine that uses the pharmaceuticals labeled with radionuclides (radiopharmaceuticals) in diagnosis and therapy. In diagnosis, radioactive substances are administered to patients and the radiation emitted is measured by gamma cameras. In therapy, radionuclides are administered to treat disease or provide palliative pain relief. Nuclear medicine differs from most other imaging modalities in that the tests primarily show the physiological function of the system being investigated as opposed to the anatomy. Radioimmunoassay (RIA) is a highly sensitive laboratory technique used to measure minute amounts of substances including antigens, hormones, and drugs present in the body. The substance or antigen (a foreign substance in the body that causes antibody production) to be measured is injected into an animal, causing it to produce antibodies. Serum containing the antibodies is withdrawn and treated with a radioactive antigen and later with a nonradioactive antigen. Measurements of the amount of radioactivity are then used to determine the amount of antigen present.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Single-Photon Emission-Computed Tomography Medicine & Life Sciences
Corpus Striatum Medicine & Life Sciences
Dopamine Plasma Membrane Transport Proteins Medicine & Life Sciences
Serotonin Plasma Membrane Transport Proteins Medicine & Life Sciences
Healthy Volunteers Medicine & Life Sciences
Dopamine D2 Receptors Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Dopamine D3 Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2018

Research Output 1993 2019

Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma

Yi, W. L., Chen, T. P., Chiu, N-T., Liu, C. S. & Lin, Y. H., 2019 Mar 1, In : Clinical Nuclear Medicine. 44, 3, p. 240-243 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma

Huang, Y. C., Li, S. H., Lu, H. I., Hsu, C. C., Wang, Y. M., Lin, W. C., Chen, C. J., Ho, K. W. & Chiu, N-T., 2019 Jan 1, In : PLoS ONE. 14, 1, e0210055.

Research output: Contribution to journalArticle

squamous cell carcinoma
uptake mechanisms
lesions (animal)
Dopamine Plasma Membrane Transport Proteins
Attention Deficit Disorder with Hyperactivity
P300 Event-Related Potentials
Sex Education
Caudate Nucleus